Fleiz Bautista C, Medina-Mora ME

Language: English
References: 12
Page: 205-206
PDF size: 105.88 Kb.

Text Extraction

The epicenter of fentanyl use in Mexico has been in Tijuana and Mexicali, two cities on the U.S. border characterized by drug use (Rafful et al., 2015; Goodman-Meza et al., 2022). In recent years, these cities have seen the largest seizures of fentanyl in the country (Comisión Nacional de Salud Mental y Adicciones, 2024a) as well as the exponential growth of its use and that of other adulterants such as xylazine.
Fentanyl is a much more potent synthetic opioid agonist than morphine and heroin, used for pain management in medical settings. Its illegal production in clandestine laboratories in liquid, pill or powder form has created a major opioid crisis in the United States, causing over 80,000 overdose deaths in 2023 (National Center for Health Statistics, 2023).

REFERENCES

1. Comisión Nacional de Salud Mental y Adicciones (Eds). (2024a). Informe de lademanda y oferta de Fentanilo en México: generalidades y situación actual.CDMX: Secretaría de Salud.

2. Comisión Nacional de Salud Mental y Adicciones (Eds.). (2024b). Alerta parapersonal de salud y primeros respondientes de ciudades fronterizas de México.Retrieved from https://www.gob.mx/salud/conadic/documentos/alerta-parapersonal-de-salud-y-primeros-respondientes-de-ciudades-fronterizas-demexico - Access date August 12, 2024

3. Fleiz, C., Arredondo, J., Chavez, A., Pacheco, L., Segovia, L. A., Villatoro, J. A.,Cruz, S. L., Medina-Mora, M. E., & de la Fuente, J. R. (2020). Fentanyl isused in Mexico's northern border: current challenges for drug health policies.Addiction, 115(4), 778-781. https://doi.org/10.1111/add.14934

4. Fleiz-Bautista, C., Domínguez-García, M., Villatoro-Velázquez, J. A., VázquezQuiroz, F., Zafra-Mora, E., Sánchez-Ramos R., Resendiz-Escobar, E., BustosGamiño M., & Medina-Mora M. E. (2019). Cuqueando la Chiva: Contextosdel consumo de heroína en la frontera norte de México… Ciudad de México,México: INPRFM.

5. Friedman, J., Bourgois, P., Godvin, M., Chavez, A., Pacheco, L., Segovia, L. A.,Beletsky, L., & Arredondo, J. (2022). The introduction of fentanyl on the USMexico border: An ethnographic account triangulated with drug checking datafrom Tijuana. International Journal on Drug Policy, 104, 103678. https://doi.org/10.1016/j.drugpo.2022.103678

6. Goodman-Meza, D., Arredondo, J., Slim, S., Angulo, L., Gonzalez-Nieto, P., Loera,A., Shoptaw, S., Cambou, M. C., & Pitpitan, E. V (2022). Behavior change afterfentanyl testing at a safe consumption space for women in Northern Mexico:A pilot study. International Journal on Drug Policy, 106, 103745. https://doi.org/10.1016/j.drugpo.2022.103745

7. Gupta, R., Holtgrave, D. R., & Ashburn, M. A. (2023). Xylazine - Medical and PublicHealth Imperatives. New England Journal of Medicine, 388(24), 2209-2212.https://doi.org/10.1056/NEJMp2303120

8. National Center for Health Statistics. (2023). U.S. Overdose Deaths Decrease in 2023,First Time Since 2018. Retrieved from https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2024/20240515.htm - Access date August 12, 2024

9. Rafful, C., Wagner, K. D., Werb, D., González-Zúñiga, P. E., Verdugo, S., Rangel, G.,& Strathdee, S. A. (2015). Prevalence and correlates of neck injection amongpeople who inject drugs in Tijuana, Mexico. Drug and Alcohol Review, 34(6),630-636. https://doi.org/10.1111/dar.12264

10. Volkow, N. D. (2020). Stigma and the Toll of Addiction. The New England Journal ofMedicine, 382(14), 1289-1290. https://doi.org/10.1056/NEJMp1917360

11. Zhang, M., Zhang, Y., & Kong, Y. (2019). Interaction between social pain andphysical pain. Brain Science Advances, 5(4), 265-273. https://doi.org/10.26599/BSA.2019.9050023

12. Zhu, D. T., Friedman, J., Bourgois, P., Montero, F., & Tamang, S. (2023). Theemerging fentanyl-xylazine syndemic in the USA: challenges and futuredirections. Lancet, 402(10416), 1949-1952. https://doi.org/10.1016/S0140-6736(23)01686-0